NM_020989.4:c.432C>G
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_020989.4(CRYGC):c.432C>G(p.Tyr144*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_020989.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CRYGC | NM_020989.4 | c.432C>G | p.Tyr144* | stop_gained | Exon 3 of 3 | ENST00000282141.4 | NP_066269.1 | |
LOC100507443 | NR_038437.1 | n.98-8760G>C | intron_variant | Intron 1 of 2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1
The Y144X variant in the CRYGC gene has been reported previously in a family with nonsyndromic autosomal dominant congenital cataracts and also in a family with autosomal dominant congenital cataracts with microcornea (Zhong et al, 2017; Sun et al., 2017). This variant is predicted to cause loss of normal protein function through protein truncation, as it results in loss of the last 31 amino acids. The Y144X variant is not observed in large population cohorts (Lek et al., 2016). We interpret Y144X as a pathogenic variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at